Time for Small Cap to Shine?

Small and micro-cap stocks have underperformed the market for quite a while now. Since I started Tailwinds in August of 2016, the Russell 2000...

Post Traumatic Investment Disease Redux? Nah, Just A Dose Of Reality

Having survived the rocky cliffs of Moab, I think I jinxed myself with last week's cover photo asking "What could go wrong?" Turns out...

Dyadic Updates Market on COVID-19 Initiatives

Tailwinds' Take: DYAI has a number of balls in the air when it comes to Covid-19. We continue to believe that the pandemic is...

The Final Push…

Like the debate, 2020 has been a sh**-show. Pandemics, political divisiveness, fires...it's not been a beach party to say the least. Yet, here we stand...

Wrapping Up A Chaotic Week

Markets were very volatile this past week, trading back and forth like a game of ping-pong. There's little doubt in my mind that the...

Dyadic and VTT Are Developing an Efficient New Production Method for Covid-19 Vaccines

Tailwinds' Take: Dyadic's disruptive technology is being explored for use in vaccine production by many partners. There's an excellent chance they will be successfully...

West Bound and Down

After fortuitously sheltering in place on the east coast for seven weeks, we are heading back for CA this week. We seem to have,...

Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development

Tailwinds' Take: Jiangsu is one of the two largest pharmaceutical companies in China. "This is a major shot across the bow of big pharma,"...

This Week at Tailwinds

Stocks continued to climb the proverbial wall of worry last week, with the S&P briefly managing to touch an all-time high and the Russell...

Dyadic Announces Second Quarter 2020 Results and Highlights Recent Company Progress

Tailwinds Take: Dyadic continues to execute on their business but the street will likely focus on the ATM and pressure the shares. When we...

OnTrak For A Great Year

Telehealth was the all the rage this past week. First The Centers for Medicare & Medicaid Services (CMS) is proposing changes to expand telehealth...

Random Thoughts on a Number of Stocks…

There's certainly a lot going on in the world at large right now and none of it seems too good. Covid-19 refuses to go...

Dyadic International Announces Fully Funded Human Health R&D Collaboration with a Top Five Pharmaceutical...

Tailwinds' Take: as we said recently, the onset of Covid-19 is driving recognition and rapid adoption of DYAI's C1 technology. The pipeline is bursting...

Previewing the 2nd Half of 2020…and Other Updates From The Week

Greetings from...wait for it...Ashland Oregon. Yes, it was so good, we came back for more. The weather here is great, the riding is outstanding...

Dyadic Announces Two New Fully Funded Collaborations with Leading Global Animal Health Companies

Tailwinds' Take: the momentum in Dyadic's business is growing. They are on the verge of changing the production of a large chunk of the...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.